Rey MCW, Bonamigo RR

Idioma: Portugués
Referencias bibliográficas: 27
Paginas: 49-56
Archivo PDF: 225.23 Kb.

FRAGMENTO

No tiene resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. Rivitti EA. Alopecia areata: revisão e atualização. An Bras Dermatol 2005; 80(1):57-68.

2. MacDonald Hull SP, Wood ML, et al. Guidelines for the management of alopecia areata. Br J Dermatol 2003;149:692-9.

3. Price VH. Therapy of alopecia areata: on the cusp and in the future. J Investig Dermatol Symp Proc. 2003;8:207-11.

4. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol 2000;42:549-66.

5. Tang L, Sundberg JP, Lui H, Shapiro J. Old wine in new bottles: reviving old therapies for alopecia areata using rodent models. J Invest Dermatol Symp Proc. 2003 Oct;8:212-6.

6. Norris D. Alopecia areata: Current state of knowledge. J Am Acad Dermatol 2004;51:p16-17.

7. Berth-Jones J, Abdullah A. Alopecia areata. In: Lebwohl M, Heymann WR, Berth-Jones J, Coulson I, editors. Treatment of Skin Disease – Comprehensive Therapeutic Strategies, Mosby, 2002.

8. Price VH. Treatment of Hair Loss. N Engl J Med 1999;341:964-73.

9. Olsen EA et al. Alopecia areata investigational assessment guidelines – part II. J Am Acad Dermatol 2004;51:440-7.

10. Meidan VM, Touitou E. Treatments for androgenetic alopecia and alopecia areata: current options and future prospects. Drugs 2001;61:53-69.

11. Moreno-Arias G, Lacueva L, Ferrando J. Actualización en el tratamiento de la alopecia areata. In: Ferrando J, editor. Casos Clínicos en Tricología. Alopecia no Cicatricial, Aula Médica Ediciones, 2004.

12. Freyschmidt-Paul P, Happle R, McElwee KJ, Hoffmann R. Alopecia areata: treatment of today and tomorrow. J Invest Dermatol Symp Proc. 2003;8:12-7.

13. Charuwichitratana S, Wattanakrai P, Tanrattanakorn S. Randomized double-bind placebo-controlled trial in the treatment of alopecia areata with 0,25% desoximetasone cream. Arch Dermatol 2000;136:1276-7.

14. Tosti A, Piraccini BM, Pazzaglia M, Vincenzi C. Clobetasol propionate 0,05% under occlusion in the treatment of alopecia totalis/universalis. J Am Acad Dermatol 2003 Jul;49:96-8.

15. McMichael A, et al. Alopecia areata in the United States: Outpatient utilization and common prescribing patterns. J Am Acad Dermatol 2005 March;52:pP112.

16. Ferrando J, Moreno-Arias GA. Multi-injection plate for intralesional corticosteroid treatment of patchy alopecia areata. Dermatol Surg 2000;26:690-1.

17. D’Ovidio R, Claudatus J, Di Prima T. Ineffectiveness of imiquimod therapy for alopecia totalis/universalis. J Eur Acad Dermatol Venereol 2002;16:416-7.

18. Freyschmidt-Paul P, Ziegler A, McElwee KJ, Happle R, Kissling S, Sundberg JP, Hoffmann R. Treatment of alopecia areata in C3H/Hej mice with the topical immunosuppressant FK506 (Tacrolimus). Eur J Dermatol 2001;11:405-9.

19. Bernardo O, Tang L, Lui H, Shapiro J. Topical nitrogen mustard in the treatment of alopecia areata: a bilateral comparison study. J Am Acad Dermatol 2003;49:291-4.

20. Ellis CN, Brown MF, et al. Sulfasalazine for alopecia areata. J Am Acad Dermatol 2002;46:541-4.

21. Namazi MR. The potential efficacy of thalidomide in the treatment of recalcitrant alopecia areata. Med Hypotheses 2003;60:513-4.

22. Perini G, Zara M. Imipramine in alopecia areata. A double-blind, placebo-controlled study. Psychother Psychosom 1994;61:195-8.

23. Cipriani R, Perini GI, Rampinelli. Paroxetine in alopecia areata. Int J Dermatol 2001;40:600-1.

24. Hay IC, Jamieson M, Ormerod AD. Randomized trial of aromatherapy. Successful treatment for alopecia areata. Arch Dermatol 1998;134:1349-52.

25. Strober BE, Siu K, et al. Etanercept does not effectively treat moderate to severe alopecia areata: An open-label study. J Am Acad Dermatol 2005;52:1082-4.

26. Posten W, Swan J. Recurrence of alopecia areata in a patient receiving etanercept injections. Arch Dermatol 2005;141:759-60.

27. Karr BR, Handa S, et al. Placebo-controlled oral pulse prednisolone therapy in alopecia areata. J Am Acad Dermatol 2005;52:287-90.